Literature DB >> 25632093

Subclinical cardiac dysfunction increases the risk of stroke and dementia: the Rotterdam Study.

Renée F A G de Bruijn1, Marileen L P Portegies1, Maarten J G Leening1, Michiel J Bos1, Albert Hofman1, Aad van der Lugt1, Wiro J Niessen1, Meike W Vernooij1, Oscar H Franco1, Peter J Koudstaal1, M Arfan Ikram2.   

Abstract

OBJECTIVE: To investigate the association between cardiac function and the risk of stroke and dementia in elderly free of clinical cardiac disease. Additionally, we investigated the relation between cardiac function and MRI markers of subclinical cerebrovascular disease.
METHODS: This study was conducted within the population-based Rotterdam Study. A total of 3,291 participants (60.8% female, age-range 58-98 years) free of coronary heart disease, heart failure, atrial fibrillation, stroke, and dementia underwent echocardiography in 2002-2005 to measure cardiac function. Follow-up finished in 2012. In 2005-2006, a random subset of 577 stroke-free people without dementia underwent brain MRI on which infarcts and white matter lesion volume were assessed.
RESULTS: During 21,785 person-years of follow-up, 164 people had a stroke and during 19,462 person-years of follow-up, 208 people developed dementia. Measures of better diastolic function, such as higher E/A ratio, were associated with a lower risk of stroke (hazard ratio [HR] 0.82; 95% confidence interval [CI] 0.69; 0.98) and dementia (HR 0.82; 95% CI 0.70; 0.96). Better systolic function, measured as higher fractional shortening, was only associated with a lower risk of stroke (HR 0.84; 95% CI 0.72; 0.98). Better diastolic function was related to a lower prevalence of silent infarcts on MRI, especially lacunar infarcts.
CONCLUSIONS: In elderly free of clinical cardiac disease, worse diastolic function is associated with clinical stroke, dementia, and silent infarcts on MRI, whereas worse systolic function is related only to clinical stroke. These findings can form the basis for future research on the utility of cardiac function as potential intervention target for prevention of neurologic diseases.
© 2015 American Academy of Neurology.

Entities:  

Mesh:

Year:  2015        PMID: 25632093     DOI: 10.1212/WNL.0000000000001289

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  16 in total

1.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

Review 2.  Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights.

Authors:  Jelena Kornej; Christin S Börschel; Emelia J Benjamin; Renate B Schnabel
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

Review 3.  Repositioning medication for cardiovascular and cerebrovascular disease to delay the onset and prevent progression of Alzheimer's disease.

Authors:  Heeyoung Lee; EunYoung Kim
Journal:  Arch Pharm Res       Date:  2020-09-09       Impact factor: 4.946

4.  Aβ Amyloid Pathology Affects the Hearts of Patients With Alzheimer's Disease: Mind the Heart.

Authors:  Luca Troncone; Marco Luciani; Matthew Coggins; Elissa H Wilker; Cheng-Ying Ho; Kari Elise Codispoti; Matthew P Frosch; Rakez Kayed; Federica Del Monte
Journal:  J Am Coll Cardiol       Date:  2016-12-06       Impact factor: 24.094

5.  Augmented risk of dementia in hypertrophic cardiomyopathy: A propensity score matching analysis using the nationwide cohort.

Authors:  Heesun Lee; Hyung-Kwan Kim; Bongseong Kim; Kyungdo Han; Jun-Bean Park; In-Chang Hwang; Yeonyee E Yoon; Hyo Eun Park; Su-Yeon Choi; Yong-Jin Kim; Goo-Yeong Cho
Journal:  PLoS One       Date:  2022-06-16       Impact factor: 3.752

6.  Left Ventricular Hypertrophy and Remodeling and Risk of Cognitive Impairment and Dementia: MESA (Multi-Ethnic Study of Atherosclerosis).

Authors:  Kasra Moazzami; Mohammad Reza Ostovaneh; Bharath Ambale Venkatesh; Mohammadali Habibi; Kihei Yoneyama; Colin Wu; Kiang Liu; Isabel Pimenta; Annette Fitzpatrick; Steven Shea; Robyn L McClelland; Susan Heckbert; Rebecca F Gottesman; David A Bluemke; Timothy M Hughes; João A C Lima
Journal:  Hypertension       Date:  2018-01-29       Impact factor: 10.190

7.  Is the time ripe for new diagnostic criteria of cognitive impairment due to cerebrovascular disease? Consensus report of the International Congress on Vascular Dementia working group.

Authors:  Robert Perneczky; Oren Tene; Johannes Attems; Panteleimon Giannakopoulos; M Arfan Ikram; Antonio Federico; Marie Sarazin; Lefkos T Middleton
Journal:  BMC Med       Date:  2016-11-03       Impact factor: 8.775

8.  Orthostatic Hypotension and the Long-Term Risk of Dementia: A Population-Based Study.

Authors:  Frank J Wolters; Francesco U S Mattace-Raso; Peter J Koudstaal; Albert Hofman; M Arfan Ikram
Journal:  PLoS Med       Date:  2016-10-11       Impact factor: 11.069

9.  Stroke Incidence and Impact of Continuous-Flow Left Ventricular Assist Devices on Cerebrovascular Physiology.

Authors:  William K Cornwell; Amrut V Ambardekar; Tomio Tran; Jay D Pal; Luis Cava; Justin Lawley; Takashi Tarumi; Christy L Cornwell; Keith Aaronson
Journal:  Stroke       Date:  2019-02       Impact factor: 7.914

10.  Atrial Fibrillation, Cognitive Decline And Dementia.

Authors:  Alvaro Alonso; Antonio P Arenas de Larriva
Journal:  Eur Cardiol       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.